These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8069756)

  • 1. Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon). Vitreon Study Group.
    Carroll BF; Peyman GA; Mehta NJ; Millsap CM; Greve MD; Dunlap WA; Lee KJ; Ma PE
    Can J Ophthalmol; 1994 Apr; 29(2):66-9. PubMed ID: 8069756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study.
    Millsap CM; Peyman GA; Mehta NJ; Greve MD; Lee KJ; Ma PE; Dunlap WA
    Ophthalmic Surg; 1993 Nov; 24(11):759-63. PubMed ID: 8290216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroperhydrophenanthrene (Vitreon) as a short-term vitreous substitute after complex vitreoretinal surgery.
    Tanji TM; Peyman GA; Mehta NJ; Millsap CM
    Ophthalmic Surg; 1993 Oct; 24(10):681-5. PubMed ID: 8259246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study.
    Verma LK; Peyman GA; Wafapoor H; Greve MD; Millsap CM; Adile SL
    Ophthalmic Surg; 1995; 26(1):29-33. PubMed ID: 7746621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair.
    Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ; Schiffman JC
    Ophthalmology; 2000 May; 107(5):860-5. PubMed ID: 10811075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group.
    Kertes PJ; Wafapoor H; Peyman GA; Calixto N; Thompson H
    Ophthalmology; 1997 Jul; 104(7):1159-65. PubMed ID: 9224470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adjunctive use of perfluoroperhydrophenanthrene (Vitreon) in diabetic vitrectomy.
    Wafapoor H; Kertes PJ; Navarro GC; Peyman GA; Meffert S; Ganiban GJ; Vierling S
    Int Ophthalmol; 1998-1999; 22(2):89-96. PubMed ID: 10472768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group.
    Soheilian M; Peyman GA; Wafapoor H; Navarro GC; Thompson H
    Int Ophthalmol; 1996-1997; 20(5):241-9. PubMed ID: 9112194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative complications of perfluoroperhydrophenanthrene: subretinal perfluorocarbon, retinal slippage and residual perfluorocarbon. Vitreon Study Group.
    Meffert S; Peyman GA
    Can J Ophthalmol; 1999 Aug; 34(5):272-80. PubMed ID: 10486686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon).
    Schulman JA; Peyman GA; Blinder KJ; Alturki WA; Desai UR; Nelson NC
    Jpn J Ophthalmol; 1993; 37(1):70-7. PubMed ID: 8320868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
    Loewenstein A; Humayun MS; de Juan E; Campochiaro PA; Haller JA
    Ophthalmology; 2000 Jun; 107(6):1078-82. PubMed ID: 10857826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreon, a new perfluorocarbon.
    Blinder KJ; Peyman GA; Paris CL; Dailey JP; Alturki W; Lui KR; Gremillion CM; Clark LC
    Br J Ophthalmol; 1991 Apr; 75(4):240-4. PubMed ID: 2021595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of retinal detachment associated with choroidal coloboma using perfluoroperhydrophenanthrene (Vitreon).
    Lee KJ; Peyman GA; Paris CL; Alturki WA; Desai UR
    Ophthalmic Surg; 1992 Aug; 23(8):553-4. PubMed ID: 1508487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of traumatic retinal detachment with vitreon in children.
    Cekiç O; Batman C; Totan Y; Aslan O; Ozalp S
    Int Ophthalmol; 1999; 23(3):145-8. PubMed ID: 11456251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreon, a short-term vitreoretinal tamponade.
    Blinder KJ; Peyman GA; Desai UR; Nelson NC; Alturki W; Paris CL
    Br J Ophthalmol; 1992 Sep; 76(9):525-8. PubMed ID: 1420054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitrectomy plus air tamponade for treatment of retinal detachment with proliferative vitreoretinopathy].
    Gao RL
    Zhonghua Yan Ke Za Zhi; 1992 Mar; 28(2):80-2. PubMed ID: 1425038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy.
    Chang S; Ozmert E; Zimmerman NJ
    Am J Ophthalmol; 1988 Dec; 106(6):668-74. PubMed ID: 3195646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal detachment with proliferative vitreoretinopathy: surgical results with scleral buckling, closed vitrectomy, and intravitreous air injection.
    Ho PC; McMeel JW
    Br J Ophthalmol; 1985 Aug; 69(8):584-7. PubMed ID: 4016057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [C2F6 in the treatment of retinal detachment associated to PVR: therapeutic trial].
    Mouries O; Bonnet M
    J Fr Ophtalmol; 1992; 15(11):601-4. PubMed ID: 1298772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C3F8 in the treatment of retinal detachment associated with vitreoretinal proliferation].
    Fleury J; Bonnet M
    J Fr Ophtalmol; 1989; 12(2):89-94. PubMed ID: 2794357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.